Cervical dysplasia on cervicovaginal papanicolaou smear among HIV-1- infected pregnant and nonpregnant women

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 3, 1999, Pages 300-307

  Stratton, Pamela ^a   Gupta, Prabodh ^b   Riester, Katherine ^c   Fox, Harold ^d   Zorrilla, Carmen ^e   Tuomala, Ruth ^f,g   Eriksen, Nancy ^h   Vajaranant, Mark ⁱ   Minkoff, Howard ^j   Fowler, Mary Glenn ^k  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d New York Presbyterian Hospital Columbia University Medical Center   (United States)

^e UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^f HARVARD UNIVERSITY   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

^h BAYLOR UNIVERSITY   (United States)

ⁱ UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^j SUNYHSC Brooklyn   (United States)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

HIV infected women; Papanicolaou smear; Pregnancy; Squamous intraepithelial lesions

Indexed keywords

ADULT; ARTICLE; FEMALE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA;

HERPES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032948309     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199903010-00014     Document Type: Article

References (31)

1. Klein RS, Ho GYF, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994;170:1404-9.
2. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC. Human Papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995;85:680-6.
3. Fruchter RG, Maiman M, Sillman FH, Camilien L, Webber CA, Kim DS. Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1994;171 :531-7.
4. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical human Papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992;79:321-7.
5. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993; 71:401-6.
6. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44.
7. Smith EM, Johnson SR, Jiang D, et al. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev 1991;15:397-402.
8. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human Papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996;174:1487-93.
9. Chan W-K, Bklock G, Bernard H-U. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol 1989;63:3261-69.
10. Korn AP, Autry M, DeRemer PA, Tan W. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:401-4.
11. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW, and the New York cervical disease study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
12. Boardman LA, Peipert JF, Sedlacek-Cooper A, Cu-Uvin S, Flanigan T, Raphael SI. Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic. Obstet Gynecol 1994;84:1016-20.
13. Centers for Disease Control and Prevention. Risk, for cervical disease in HIV-infected women: New York City. MMWR Morb Mortal Wkly Rep 1990;39:846-9.
14. Centers for Disease Control and Prevention. Sexually transmitted diseases guidelines. MMWR Morb Mortal Wkly Rep 1993;42 (RR-14):89-91
15. Sheon AR, Fox HE, Rich KC, et al. for the Women and Infants Transmission Study Group. The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: study design, methods and baseline data. J Women's Health 1996;5:69-78.
16. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-4.
17. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
18. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-15.
19. Kidd PG, Cheng S-C, Paxton H, Landay A, Gelman R. Prediction of CD4 count from CD4 percentage: experience from three laboratories. AIDS 1993;7:933-40.
20. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36.
21. Agresti A. Categorical data analysis. New York: John Wiley & Sons, 1990.
22. Schlesselman, JJ. Case control studies: design, conduct and analysis. London: Oxford University Press, 1982.
23. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
24. Belafsky P, Clark RA, Kissinger P, Torres J. Natural history of low-grade squamous intraepithelial lesions in women infected with human immunodeficiency virus [letter]. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:511-2.
25. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327: 1272-8.
26. Eckert LO, Koutsky LA, Kiviat NB, Krone MR, Stevens CE, Eschenbach DA. The inflammatory Papanicolaou smear: what does it mean? Obstet Gynecol 1995;86:360-6.
27. Wright TC, Moscarelli RD, Dole P, Ellerbrock TV, Chiasson MA, Vandevanter N. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:515-9.
28. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
29. Koutsky LA, Stevens CE, Holmes KK, et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 1992;326:1533-926.
30. Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:649-56.
31. Hording U, Iversen AK, Sebbelov A, Bock JE, Norrild B. Prevalence of human papillomavirus types 11, 16, and 18 in cervical swabs. A study of 1362 pregnant women. Eur J Obstet Gynecol Reprod Biol 1990;35:191-7.